Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 8 studies | 45% ± 12% | |
epithelial cell of proximal tubule | 5 studies | 27% ± 10% | |
enterocyte | 5 studies | 35% ± 10% | |
type II pneumocyte | 4 studies | 22% ± 11% | |
platelet | 4 studies | 22% ± 6% | |
basal cell | 4 studies | 26% ± 5% | |
ciliated cell | 4 studies | 27% ± 9% | |
goblet cell | 4 studies | 31% ± 9% | |
transit amplifying cell | 3 studies | 17% ± 3% | |
dendritic cell | 3 studies | 22% ± 3% | |
erythroblast | 3 studies | 35% ± 8% | |
hepatocyte | 3 studies | 53% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 13854.61 | 226 / 226 | 100% | 486.72 | 405 / 406 |
pancreas | 100% | 1733.16 | 327 / 328 | 98% | 134.16 | 175 / 178 |
prostate | 99% | 1417.89 | 243 / 245 | 99% | 92.33 | 495 / 502 |
intestine | 99% | 5241.51 | 954 / 966 | 99% | 229.56 | 521 / 527 |
stomach | 99% | 3056.84 | 357 / 359 | 97% | 174.36 | 277 / 286 |
ovary | 100% | 1450.39 | 180 / 180 | 95% | 56.86 | 407 / 430 |
brain | 96% | 1167.06 | 2544 / 2642 | 98% | 67.08 | 692 / 705 |
bladder | 100% | 1472.95 | 21 / 21 | 94% | 143.08 | 475 / 504 |
kidney | 100% | 4107.63 | 89 / 89 | 91% | 76.05 | 820 / 901 |
esophagus | 99% | 2172.88 | 1425 / 1445 | 91% | 71.01 | 166 / 183 |
thymus | 97% | 951.19 | 632 / 653 | 91% | 49.93 | 550 / 605 |
uterus | 96% | 1046.68 | 163 / 170 | 91% | 75.80 | 416 / 459 |
breast | 98% | 1855.08 | 448 / 459 | 86% | 50.28 | 961 / 1118 |
lung | 85% | 1245.95 | 492 / 578 | 93% | 82.66 | 1071 / 1155 |
skin | 100% | 1380.51 | 1801 / 1809 | 59% | 27.20 | 280 / 472 |
adrenal gland | 100% | 7340.37 | 258 / 258 | 42% | 65.89 | 97 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 161.13 | 1 / 1 |
muscle | 99% | 1450.38 | 795 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 59.93 | 79 / 80 |
adipose | 98% | 2114.82 | 1185 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 60.89 | 44 / 45 |
spleen | 96% | 831.25 | 231 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 1709.97 | 824 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 77% | 604.87 | 1022 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 757.92 | 651 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 21.77 | 14 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035928 | Biological process | rRNA import into mitochondrion |
GO_0009440 | Biological process | cyanate catabolic process |
GO_0000098 | Biological process | sulfur amino acid catabolic process |
GO_0051029 | Biological process | rRNA transport |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0008097 | Molecular function | 5S rRNA binding |
GO_0004792 | Molecular function | thiosulfate sulfurtransferase activity |
GO_0016784 | Molecular function | 3-mercaptopyruvate sulfurtransferase activity |
Gene name | TST |
Protein name | Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese) |
Synonyms | |
Description | FUNCTION: Formation of iron-sulfur complexes, cyanide detoxification or modification of sulfur-containing enzymes. Other thiol compounds, besides cyanide, can act as sulfur ion acceptors. Also has weak mercaptopyruvate sulfurtransferase (MST) activity (By similarity). Together with MRPL18, acts as a mitochondrial import factor for the cytosolic 5S rRNA. Only the nascent unfolded cytoplasmic form is able to bind to the 5S rRNA. . |
Accessions | ENST00000403892.7 ENST00000249042.8 Q16762 ENST00000622841.1 B1AH48 ENST00000438203.1 |